Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
BOTA > SEC Filings for BOTA > Form 8-K on 23-Dec-2013All Recent SEC Filings

Show all filings for BIOTA PHARMACEUTICALS, INC.

Form 8-K for BIOTA PHARMACEUTICALS, INC.


23-Dec-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events

On December 20, 2013, Biota Pharmaceuticals, Inc. (the "Company") issued a press release announcing that Daiichi Sankyo Company, Limited has been granted regulatory approval in Japan to manufacture and market InavirŪ Dry Powder Inhaler 20mg (generic name laninamivir octanoate) for the prevention of influenza A and B. A copy of the Company's press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 Press release dated December 20, 2013.


  Add BOTA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for BOTA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.